Development of a multicellular in vitro model of the meningeal blood-CSF barrier to study Neisseria meningitidis infection
DOI: 10.1186/s12987-022-00379-z
Authors: Leo M. Endres; Marvin Jungblut; Mustafa Divyapicigil; Markus Sauer; Christian Stigloher; Myron Christodoulides; Brandon J. Kim; Alexandra Schubert-Unkmeir
Step 1: iPSC/ESC maintainance
day 0 ~ 1
culture “adherent” human PSC in “StemFlex medium” for “1” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should be changed once in “1” days.
Ideally, “PSC” should be obtained at the end of culture.
Step 2: Primitive streak 1
day 1 ~ 2
culture “adherent” human PSC in “DMEM/F12” for “1” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| KSR | 20 | % |
| NEAA | 1 | % |
| GlutaMAX | 0.5 | % |
| 2-mercaptoethanol | 0.07 | % |
Step 3: endothelial 1
day 2 ~ 4
culture “adherent” human PSC in “Human endothelial cell serum-free media” for “2” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| platelet-poor plasma derived serum | 1 | % |
| B27 | 1 | % |
| FGF | 2.0e-5 | g/l |
| retinoic acid | 1.0e-5 | mol/l |
Ideally, “EC” should express “PECAM1”, “CDH5”, “ZO-1”, “occludin”, “claudin-5” at the end of culture.
Step 4: endothelial 2
day 4 ~ 5
culture “device” human EC in “Human endothelial cell serum-free media” for “1” days. For ECM, use “collagen IV and fibronectin” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| platelet-poor plasma derived serum | 1 | % |
| B27 | 1 | % |
Ideally, “EC” should express “PECAM1”, “CDH5”, “ZO-1”, “occludin”, “claudin-5” at the end of culture.